Medicus Pharma Ltd. (MDCX)
NASDAQ: MDCX · Real-Time Price · USD
0.300
+0.003 (1.01%)
At close: Apr 28, 2026, 4:00 PM EDT
0.299
-0.002 (-0.50%)
After-hours: Apr 28, 2026, 7:38 PM EDT
Medicus Pharma Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 17.92 | 7.65 | 4.27 | 0.33 | 0.26 |
| Research & Development | 7.72 | 3.53 | 0.19 | 0.65 | 1.18 |
| Operating Expenses | 25.64 | 11.18 | 4.46 | 0.98 | 1.44 |
| Operating Income | -25.64 | -11.18 | -4.46 | -0.98 | -1.44 |
| Interest Expense | -0.2 | -0.08 | -1.25 | -1.1 | -0.69 |
| Interest & Investment Income | - | 0.1 | - | - | - |
| Other Non Operating Income (Expenses) | -11.84 | - | 0.67 | 0.39 | 0.08 |
| EBT Excluding Unusual Items | -37.68 | -11.16 | -5.04 | -1.69 | -2.06 |
| Other Unusual Items | -0.89 | - | -0.27 | - | - |
| Pretax Income | -47.28 | -11.16 | -5.31 | -1.69 | -2.06 |
| Earnings From Continuing Operations | -47.28 | -11.16 | -5.31 | -1.69 | -2.06 |
| Minority Interest in Earnings | 0 | - | - | - | - |
| Net Income | -47.28 | -11.16 | -5.31 | -1.69 | -2.06 |
| Net Income to Common | -47.28 | -11.16 | -5.31 | -1.69 | -2.06 |
| Shares Outstanding (Basic) | 17 | 10 | 3 | 2 | 3 |
| Shares Outstanding (Diluted) | 17 | 10 | 3 | 2 | 3 |
| Shares Change (YoY) | 79.68% | 176.45% | 84.60% | -41.41% | - |
| EPS (Basic) | -2.74 | -1.16 | -1.53 | -0.90 | -0.64 |
| EPS (Diluted) | -2.74 | -1.16 | -1.53 | -0.90 | -0.64 |
| EBITDA | - | -11.08 | - | - | - |
| D&A For EBITDA | - | 0.1 | - | - | - |
| EBIT | -25.64 | -11.18 | -4.46 | -0.98 | -1.44 |
Source: S&P Capital IQ. Standard template.
Financial Sources.